NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravis Aarhus, Denmark, 10 March 2026 – NMD Pharma A/S, a ...
Abstract: This study develops an efficient measurement method for radiated emissions from automotive wire harnesses. The proposed measurement method utilizes the transfer function (T F) between a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results